Clinical Trial Update: Treatment Outcomes in PASC Patients With Neurocognitive Impairment

View source ↗

Summary

A completed clinical trial from Ohio State University reports treatment outcomes for patients with Long COVID who have neurocognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Ohio State University | Conditions: Long COVID | Status: COMPLETED